The Finasucre Group acquires the Dikansky family's holdings in SGD

Avignon, 25 February 2013 - Naturex, the global leader in speciality plant-based natural ingredients, informs its shareholders of the new ownership structure of the share capital of SGD, the company's lead shareholder.

The Finasucre Group strengthens its stake in SGD

In July 2011, the Finasucre Group became a shareholder of SGD to strengthen the structure of this family holding company and provide it with resources to support Naturex in pursuing external growth opportunities.

Following Jacques Dikansky's passing and, in keeping with the spirit of the agreement concluded when Finasucre Group first became a SGD shareholder, Jacques Dikansky's children sold their entire stake in SGD.

Pursuant to the completion of this transaction on 22 February 2013, the Finasucre Group now holds 98.79% of SGD's share capital with the balance held by selected members of Naturex's Executive Committee.

Finasucre Group's acquisition of these holdings is consistent with its initial investment in SGD and confirms its willingness to continue its long-term commitment in supporting Naturex in the implementation of its development strategy.

Changes in the composition of Naturex's Board of Directors

This transaction results in changes in the composition of Naturex's Board of Directors, pursuant to the resignation of Olivier Dikansky from his position as director, and the appointment of Charles Feys, Secretary General of Finasucre Group, as permanent representative of SGD, in replacement of Isabelle Dikansky.

The Board of Directors, in today's meeting, has also co-opted as a director, Hélène MARTEL-MASSIGNAC, Chief Executive Officer of CARAVELLE.

Pursuant to these changes, the composition of Naturex's Board of Directors is as follows:

• Thierry Lambert
  
  Chairman and Chief Executive Officer of Naturex


• Stéphane Ducroux
  
  Chief Operating Officer for the America/Asia-Pacific Regions
  
  and Vice Chairman of Naturex Inc.


• Olivier Lippens
  
  Executive Officer of Finasucre


• Paul Lippens
  
  Executive Officer of Finasucre


• Hélène Martel-Massignac
  
  Chief Executive Officer of Caravelle


• SGD
  
  Represented by Charles Feys, Secretary General of Finasucre

It is furthermore reminded that the appointment of the FSI to Naturex's Board will be submitted to the next General Meeting.

Naturex's shareholder structure is henceforth as follows:

* Based on 8,727,344 voting rights exercisable at 31/01/2013

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.fr

• Financial schedule
  
  
  
  
  
  
  

  - Results - FY 2012

  27 March 2013

  
  

• Upcoming events
  
  
  
  
  
  
  

  - Analysts meeting (SFAF - French Society of Financial Analysts), Paris

  28 March 2013

  
  

Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B

Total number of shares comprising the share capital: 7,728,769 ISIN FR0000054694 Naturex is a component of the CAC Small and Gaïa indexes. Naturex is eligible for the "long only" Deferred Settlement Service (SRD). Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.

SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

About Naturex

Naturex is a global leader in speciality plant-based natural ingredients.

The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 1,300 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 20 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).

Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.

• Contacts

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free